promenakin (F-652) - Yifan Pharma
"#TCTM20 Ponce: F652 responders had more microbiome diversity at baseline and after treatment, preserved blautia abundance" (@hemedoc) Feb 21, 2020 
https://twitter.com/hemedoc/status/1230885242514395138
 
Feb 21, 2020
 
 
0cfd72ef-9d96-4d89-8612-a60f9032933c.jpg

f987af1b-7dfd-46f6-a89c-d8700ed263fb.jpg

c3e20f04-4c78-4ba4-8658-2e91f1433dad.jpg

3a84db51-b802-4900-a6cc-8497aa588b97.jpg